SCHEMBL23935936

SCHEMBL23935936

Cc1cccc2cnc(N)cc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 1/20 0.53
CYP1A2 P05177 5/20 0.47
CYP2A6 P11509 4/20 0.47
NOS3 P29474 2/20 0.47
NOS1 P29475 2/20 0.47
NOS2 P35228 2/20 0.47
ALDH1A1 P00352 3/20 0.43
HPGD P15428 2/20 0.43
HSD17B10 Q99714 1/20 0.43
FGFR1 P11362 1/20 0.41
ABL1 P00519 2/20 0.40
EGFR P00533 1/20 0.39
BACE1 P56817 1/20 0.39
MAP4K4 O95819 2/20 0.39
KDM4E B2RXH2 1/20 0.38
PSMD14 O00487 1/20 0.38
MITF O75030 1/20 0.38
LMNA P02545 1/20 0.38
POLB P06746 1/20 0.38
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8404533 0.80 CYP1A2 (0.57) CYP1A2CYP2A6ALDH1A1HPGDHSD17B10
SCHEMBL4021192 0.80 PDPK1 (0.57) PDPK1CYP1A2ALDH1A1HPGDHSD17B10
SCHEMBL30175614 0.80 PDPK1 (0.57) PDPK1CYP1A2ALDH1A1HPGDHSD17B10
SCHEMBL559707 0.77 PDPK1 (0.53) PDPK1FGFR1EGFRMAP4K4MAPT
SCHEMBL559239 0.77 PDPK1 (0.53) PDPK1CYP1A2NOS1FGFR1EGFR
SCHEMBL18379303 0.77 CYP1A2 (0.47) CYP1A2CYP2A6ALDH1A1HPGDHSD17B10
SCHEMBL558996 0.77 PDPK1 (0.53) PDPK1CYP1A2CYP2A6FGFR1MAP4K4
SCHEMBL559279 0.77 NOS3 (0.47) PDPK1CYP1A2CYP2A6NOS3NOS1
SCHEMBL19044152 0.77 CYP1A2 (0.47) CYP1A2CYP2A6ALDH1A1HPGDHSD17B10
SCHEMBL30871777 0.77 PDPK1 (0.53) PDPK1CYP1A2NOS1FGFR1EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3896064-A1 4,6-DIAMINO-QUINOLINE-3-CARBONITRILE DERIVATIVES AS CANCER OSAKA THYROID (COT) MODULATORS FOR TREATING CROHN'S DISEASE AND ULCERATIVE COLITIS Gilead Sciences, Inc. (US) 2021-10-20 EP disclosed